Delivery Order SPE2DR25D1100-SPE2DR26FCS8E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,833.32 to AmerisourceBergen Drug Corp for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its...
- The Defense Logistics Agency awarded a $22,503.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This is a non-set-aside competitive award with an ultimate completion date of April 22, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,998.93 by the Defense Logistics Agency on November 12, 2025, for the supply of Forteo (teriparatide) 560 micrograms/2.24 milliliters pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 13, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Forteo is a prescription...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections in a 2.24 mL formulation. This $4,289.89 firm fixed-price delivery order, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO (teriparatide) 560 mcg/2.24 mL pen injections valued at $7,529.58. The award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a firm fixed price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office as a primary...
- The Defense Logistics Agency awarded a $2,749.98 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used to treat osteoporosis and bone-related...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,601.43 to supply Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 31, 2025, and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $11,239.10 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This competitive, firm fixed-price delivery order is set to be completed by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-line procurement of this specialized pharmaceutical product to support federal medical supply...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $3,413.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injection) on December 9, 2025, with completion targeted for December 10, 2025. This non-set-aside competitive award represents a single delivery order fulfillment for a specialty pharmaceutical product used in osteoporosis treatment. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS8EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,741.51 to AmerisourceBergen Drug Corp for Forteo (teriparatide) 560 mcg/2.24 mL pen injections on December 4, 2025, with completion scheduled for December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The product will be performed and delivered from the company's Conshohocken facility. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen Drug Corp's established capability to meet federal medical supply requirements through open competition across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/3/25 |